The National Times - US authorizes Covid booster shots for children 5 to 11

US authorizes Covid booster shots for children 5 to 11


US authorizes Covid booster shots for children 5 to 11
US authorizes Covid booster shots for children 5 to 11 / Photo: © AFP/File

Children as young as five in the United States will now be able to receive a booster dose of Pfizer's Covid-19 vaccine, the nation's health authorities announced Tuesday.

Change text size:

The US Food and Drug Administration authorized children in the 5-11 group to receive the booster in order to "provide continued protection against Covid-19," FDA Commissioner Robert Califf said in a statement.

A committee of experts from the US Centers for Disease Control and Prevention (CDC) is scheduled to meet Thursday on the issue.

Children will become eligible for the booster at least five months after completing their initial vaccine doses. The dosage is 10 micrograms for both the initial shots and the booster, compared to 30 for those 12 and older.

The authorization comes as Covid cases are on the rise in the United States, with approximately 90,000 cases reported per day. Hospitalizations are also up.

"While it has largely been the case that Covid-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease," Califf said.

There are 28 million children who fall into the 5-11 age range in the United States, and there have been 4.8 million Covid cases and about 360 deaths among them so far, according to CDC figures.

This age group has been eligible to receive the initial two doses of Pfizer's vaccine since November 2021, but less than 30 percent of them have so far.

The FDA on Tuesday again emphasized the importance of vaccination to prevent severe cases of Covid-19.

Children under five are not yet eligible for vaccination, but an independent panel of experts is scheduled to meet in June to review clinical trial data from Pfizer and Moderna about this age group.

S.Mitchell--TNT

Featured

Langley Businesses Navigate Tariff Pressures Amid Holiday Shopping Push

Independent businesses in Langley are facing heightened financial pressures from recent tariff implementations as they navigate the crucial holiday shopping period. While supply chain disruptions threaten inventory and pricing, local advocates highlight that spending at community retailers recirculates significantly more wealth within the region than purchases made through multinational or online platforms.

ALIX LASERS shareholders remove Michael Sobitsch as managing director in view of the circumstances

In an interview with BERLINER TAGESZEITUNG, the shareholders of Alix Lasers GmbH in Austria said that, after acquiring 100 per cent of the company’s shares, they removed Michael Sobitsch from his position as managing director yesterday, 19 November 2026, in Vienna, Austria. In view of the circumstances, they removed him from office with immediate effect, without granting him discharge for his tenure as managing director.

Analysts Identify Key Metal Stocks Amid 38% Commodity Slide

With silver, copper, and gold prices falling up to 38% from recent peaks due to global economic concerns, technical analysts at Angel One and SAMCO Securities have identified specific trading opportunities in major metal equities. The firms' research highlights both bearish setups for stocks like Hind Copper and SAIL, alongside potential bullish breakouts for APL Apollo Tubes and Jindal Stainless.

Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year

Saudi Arabia's Public Investment Fund (PIF) has been named the world’s most valuable sovereign wealth fund brand for the third consecutive year, according to a new assessment by Brand Finance. The ranking highlights the fund's growing global influence and financial strength as it advances its strategic objectives under Vision 2030.

Change text size: